Transcriptional regulation of T cell immunity
T细胞免疫的转录调控
基本信息
- 批准号:10008141
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdoptive TransferBacterial InfectionsBody SurfaceCD8-Positive T-LymphocytesCellsChronicColonCommunicable DiseasesCytometryDataEffector CellFaceGene ExpressionGene Expression ProfilingGene TargetingGenesGenetic TranscriptionGoalsHIV/HCVHealthHeterogeneityHost DefenseImmune responseImmune systemImmunityImmunologic MemoryInfectionKidneyLiverMeasurementMemoryMethodsMolecularMorbidity - disease ratePathway interactionsPhasePopulationProteinsRNA InterferenceReportingSentinelSmall IntestinesSpecific qualifier valueT cell regulationT memory cellTissuesTranscriptional RegulationTransgenic OrganismsVaccine DesignVaccinesValidationVeteransWorkadaptive immunityantigen-specific T cellsbasecell typefirst respondergenome-wideimprovedin vivoinnovationinsightintestinal epitheliumknock-downmicrobialmilitary veteranmortalityneutralizing antibodynovelresponsesingle-cell RNA sequencingsmall hairpin RNAtranscriptomevaccination strategyvaccine development
项目摘要
Summary
Infectious diseases, including Hepatitis C (HCV) and HIV, remain important health problems among Veterans.
Development of vaccines for infectious diseases is therefore a key priority. Immunologic memory is a cardinal
feature of adaptive immunity and an important goal of vaccination strategies. Traditional vaccination strategies
are very effective at generating neutralizing antibodies, but not effective T cell memory. A key reason for the
current lack of effective vaccines against many infectious diseases is that we do not yet know how to make
vaccines that generate robust T cell memory. Thus, a fundamental understanding of how memory cells are
formed is a crucial first step in rational vaccine design for infectious diseases.
摘要
包括丙型肝炎和艾滋病毒在内的传染病仍然是退伍军人的重要健康问题。
因此,开发传染病疫苗是一个关键的优先事项。免疫记忆是最重要的
获得性免疫的特点和疫苗接种策略的一个重要目标。传统的疫苗接种策略
在产生中和抗体方面非常有效,但不能有效地记忆T细胞。一个关键原因是
目前缺乏针对许多传染病的有效疫苗是我们还不知道如何制造
产生强大T细胞记忆的疫苗。因此,对存储单元是如何
形成是合理设计传染病疫苗的关键第一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John T Chang其他文献
Erratum: Epigenetic landscapes reveal transcription factors that regulate CD8+ T cell differentiation
勘误表:表观遗传景观揭示了调节 CD8 T 细胞分化的转录因子
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:30.5
- 作者:
Bingfei Yu;Kai Zhang;J. Milner;Clara Toma;Runqiang Chen;James P Scott;Renata M Pereira;Shane Crotty;John T Chang;M. Pipkin;Wei Wang;A. Goldrath - 通讯作者:
A. Goldrath
Drug Insight: antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
药物洞察:肿瘤坏死因子-α拮抗剂在炎症性肠病治疗中的应用
- DOI:
10.1038/ncpgasthep0447 - 发表时间:
2006-04-01 - 期刊:
- 影响因子:51.000
- 作者:
John T Chang;Gary R Lichtenstein - 通讯作者:
Gary R Lichtenstein
John T Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John T Chang', 18)}}的其他基金
Using single-cell RNA-seq to interrogate host immunity to pathogens
使用单细胞 RNA-seq 探究宿主对病原体的免疫力
- 批准号:
9367846 - 财政年份:2017
- 资助金额:
-- - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
-- - 项目类别: